SOUTH SAN FRANCISCO, Calif., Aug. 5, 2010 (GLOBE NEWSWIRE) -- Hana Biosciences (OTCBB:HNAB), a biopharmaceutical company focused on strengthening the foundation of cancer care, today announced the appointment of Robert (Bob) Spiegel, M.D., FACP, to the Company’s Board of Directors. Dr. Spiegel was employed at Schering Plough for 26 years where he was deeply involved in clinical research culminating with his position as Chief Medical Officer.
